Giannis Mountzios: New ESMO Book on Thoracic Oncology Now Available for Members - OncoDaily Giannis Mountzios: New ESMO Book on Thoracic Oncology Now Available for Members / cancer, ESMO, Giannis Mountzios, Lung cancer, Marina Garassino, OncoDaily,

New ESMO Book on Thoracic Oncology Now Available for Members - Giannis Mountzios

@myesmo.bsky.social @drgreeklungcancer.bsky.social

oncodaily.com/voices/giann...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ThoracicOncology

📣 All #ELCC26 sessions with speaker permission are now online for registered delegates & ESMO members on #OncologyPRO 

Watch on demand and stay at the forefront of #ThoracicOncology

🔗 https://ow.ly/hsgC50YB30R

📣 They’re here! Late-breaking abstracts (LBAs) for #ELCC26 are now online.

Explore the latest data driving progress in #ThoracicOncology.

🔗 https://ow.ly/OV0y50YxzqY

#esmomeetings

We’re excited to announce that ONCrg will be attending ELCC 2026! We will be analyzing the latest data releases and connecting with global leaders in thoracic oncology.
ONCrg Conference details: lnkd.in/gBmADVyb

#ELCC26 #LungCancer #Oncology #NSCLC #MedicalAffairs #ONCrg #ThoracicOncology

Members of our #thoraciconcology team attended the IASLC 2026 Targeted Therapies of Lung Cancer Meeting #TTLC26 last week, a conference sharing the latest breakthroughs in clinical research and targeted therapies for #lungcancer.

Ready to share your work with the world? 🌎

Abstract submissions for #WCLC26 are officially open! Join the largest global meeting in lung & thoracic oncology and present your research on an international stage.

Submit today: bit.ly/4tqYxoz

#LungCancer #ThoracicOncology

🎧 Available now!

Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.

Listen here: bit.ly/461LUWN

#LungCancerConsidered #ThoracicOncology

Vulnerable patients were less likely to receive subsequent therapies (60% vs 72%), suggesting that supportive care, fitness optimization, and post‑CCRT access may be critical intervention points.
#Oncology #ThoracicOncology #CancerCare #LungCancer #NSCLC #Frailty #CCRT #Cachexia

Stephen V Liu: More on the Resistance to ADCs in the Journal of Thoracic Oncology - OncoDaily Stephen V Liu: More on the Resistance to ADCs in the Journal of Thoracic Oncology / Alissa Poteete, Ash A. Alizadeh, Ashwani Kumar, cancer, Caroline M.

More on the Resistance to ADCs in the Journal of Thoracic Oncology - Stephen V Liu

@stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADCs #ThoracicOncology #LungCancer #NSCLC

👉 Early rates close 21 Jan for #ELCC26. Join the #ThoracicOncology meeting in Copenhagen, 25–28 March 2026 (onsite & online)
Practice‑oriented updates and multidisciplinary exchange.

🔗 Secure your seat: https://ow.ly/YIJq50XZXlC

📣 #ELCC26: Last chance to share your research!

⏰ Abstract deadline: tomorrow, Tuesday, 13 January, 21:00 CET
🔗 Submit now: https://ow.ly/3RmJ50XVuzK
Join global experts shaping the future of #ThoracicOncology. Your work belongs on this stage. #LungCancer #esmomeetings

👉 #ELCC26 unites every discipline in #ThoracicOncology. Intimate yet truly global. In this clip, Natasha Leighl explains why that mix matters and why ELCC is a global meeting to reach a broader audience

🔗 Submit your abstract: buff.ly/99EQAgt
⏰ 13 Jan 2026 (21:00 CET)

IASLC Introduces VIKTOR: Virtual International Knowledgebase for Thoracic Oncology Research - OncoDaily IASLC Introduces VIKTOR: Virtual International Knowledgebase for Thoracic Oncology Research / cancer, Headlines, IASLC, International Association for the

IASLC Introduces VIKTOR: Virtual International Knowledgebase for Thoracic Oncology Research

@iaslc.bsky.social

oncodaily.com/voices/thora...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #VIKTOR #ThoracicOncology #LungCancer

📣 #ELCC26: Your new data deserves a global platform

Submit your abstract now 🔗 buff.ly/a44FfwT

@drjnaidoo.bsky.social addresses the community, underscoring the value of contributing to shared progress in #ThoracicOncology
⏰ 13 Jan 2026 (21:00 CET)

Herbert Loong: IASLC Awards - Nominate a Leader Who Inspires in Thoracic Oncology - OncoDaily Herbert Loong: IASLC Awards - Nominate a Leader Who Inspires in Thoracic Oncology / cancer, Herbert Loong, OncoDaily, Oncology, Thoracic Oncology

IASLC Awards: Nominate a Leader Who Inspires in Thoracic Oncology - Herbert Loong

@herbloongmd.bsky.social

oncodaily.com/voices/herbe...

#ThoracicOncology #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

A new infographic from the #ThoracicOncology and Chest Procedures Network outlines the stepwise approach to the management of recurrent malignant #PleuralEffusion and nonexpandable lung. Learn more: www.chestnet.org/guidelines-a...
#MedSky #Oncology

NSD3遺伝子増幅、肺がんの新標的に | STELLANEWS.LIFE 国立がん研究センターと順天堂大学が、肺扁平上皮がんでNSD3遺伝子増幅が高頻度かつ予後悪化に関与することを解明。分子標的薬の可能性も。

NSD3 Gene Amplification Identified as a Novel Therapeutic Target in Lung Squamous Cell Carcinoma
stellanews.life/science_cate...

#LungCancer #NSD3 #CancerResearch #PrecisionOncology #MolecularTarget #BETinhibitor #ThoracicOncology #JapanResearch #OncologyScience

Roswell Park Care Network Expands with New Thoracic Surgery Services and Faculty | OncLive Five new faculty members join network; three at St. Joseph’s Health in Syracuse as it launches new services.

Roswell Park Care Network Expands with New Thoracic Surgery Services and Faculty
@roswellpark.bsky.social #ThoracicOncology #surgery
www.onclive.com/view/roswell...

CIOT25 Highlights by Stephen V Liu - OncoDaily CIOT25 Highlights by Stephen V Liu / Alexander Drilon, Antonio Passaro, ASCO, Ben Solomon, cancer, Cesare Gridelli, CIOT25, Filippo de Marinis, Italian

CIOT25 Highlights by Stephen V Liu
@stephenvliu.bsky.social

oncodaily.com/blog/ciot25-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CIOT25 #ThoracicOncology

📅 Mark you calendars and join us 9 July | 17:00–18:30 CEST
Join the ESTRO-IASLC Joint Webinar on Rare Thoracic Tumours!

💡 Mesothelioma, thymic cancers & oligoprogression
🎙 Expert speakers + live Q&A
🔗 Register: bit.ly/4na59nY

#IASLC #ESTRO #OncologyWebinar #ThoracicOncology #RareCancers

Join the IASLC 2025 ASCO Highlights webinar on June 27 for expert insights into the latest breakthroughs in lung cancer treatment.

👉 Register now: bit.ly/4n93NKk

#IASLC #ASCO2025 #LungCancer #Oncology #CancerResearch #ThoracicOncology #MedicalEducation @ascocancer.bsky.social

What #ASCO25 results could shift clinical practice in the UK?
💡 From immunotherapy breakthroughs to precision diagnostics—get the key insights in just 1 hour!
🗓️ Mon 16 June | 🖥️ Free BTOG webinar
www.btog.org/asco-update-...

#LCSM #LungCancer #ThoracicOncology
#BTOGASCO2025Webinar

Highlights from ELCC Day 3 - OncoDaily Highlights from ELCC Day 3 / Alessandra Dodi, Alfredo Addeo, Amol Akhade, Antonio Calles, cancer, ELCC, ELCC 2025, ELCC25, Eric Halioua, ESMO, Giannis

Highlights from ELCC Day 3

@suyogcancer.bsky.social
@drgreeklungcancer.bsky.social
@drjnaidoo.bsky.social

oncodaily.com/societies/26...

#Cancer #ELCC #ELCC2025 #ELCC25 #ESMO #LungCancer #NSCLC #OncoDaily #Oncology #ThoracicOncology #Medicine #Health

NICE has made six times more lung cancer treatment recomendations over the past ten years than in the previous decade Sixfold increase in NICE's lung cancer treatment recommendations over the past decade. NICE has recommended osimertinib for routine use on the NHS today.

#oncology #lungcancer #NICEpositiverecommendations #lungcancerpatients #ThoracicOncology #NICElungcancerguidelines #CancerDrugsFund #CDF #NICEappraisals #lungcancerguidelines #lungcancerpatients #lunghealthchecks #lungcancerscreeningprogramme #clinicaltrials
www.nice.org.uk/news/article...

AstraZeneca receives positive recommendations for lung cancer treatments - PharmaTimes NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care

#AstraZeneca #lungcancer #NICE #Imfinzi #durvalumab #Tagrisso #osimertinib #NICEpositiverecommendation #NICErecommendation #NHSEngland #NHSWales #ESSCLC #CASPIANPhaseIIItrial #overallsurvivalbenefits #ThoracicOncology #NSCLC #ADAURAphase3trial
pharmatimes.com/news/astraze...

OncoInfluencers to Follow on Social Media: Dr. Hidehito Horinouchi - OncoDaily OncoInfluencers to Follow on Social Media: Dr. Hidehito Horinouchi / cancer, Hidehito Horinouchi, LinkedIn, National Cancer Center Hospital, OncoDaily,

OncoInfluencers to Follow on Social Media: Dr. Hidehito Horinouchi

oncodaily.com/blog/hidehit...

#Cancer #NationalCancerCenterHospital #OncoDaily #Oncoinfluencer #OncoinfluencersToFollowOnSocialMedia #Oncology #ThoracicOncology #Medicine #Health

Imfinzi receives NICE recommendation for lung cancer treatment - PharmaTimes Trial results lead to new treatment option for lung cancer

#oncology #Imfinzi #durvalumab #AstraZeneca #NICErecommendation #lungcancer #lungcancerpatients #lungcancertreatment #resectablenonsmallcelllungcancer #NSCLC #AEGEANphase3trial #NHS #NSCLCpatients #ThoracicOncology #patientoutcomes #AEGEANtrial
pharmatimes.com/news/imfinzi...

Has anyone else worked on a publication for a major journal? I’d love to hear your thoughts and tips on the process!

#Oncology, #MedicalResearch, #ThoracicOncology, #CancerResearch, #LiteratureReview